Institutionelt og fondsejerskab - Købere
Større indehavere, der har åbnet nye stillinger i PharmaCyte Biotech, Inc., omfatter Raymond James Financial Inc, og Koesten, Hirschmann & Crabtree, INC. .
Denne side viser ændringer i ejerskabsstrukturen ved at notere institutioner, fonde og større aktionærer, der har øget deres beholdning eller åbnet nye positioner i den seneste rapporteringsperiode. Grønne rækker angiver nye positioner. Klik på linket ikon for at se den fulde transaktionshistorik.
Opgrader for at låse op for premium-data.
| Fil dato | Kilde | Investor | Type | Gennemsnitlig pris (Øst) |
Aktier | Δ Aktier (%) |
Rapporteret Værdi ($1000) |
Δ Værdi (%) |
Port Alloc (%) |
|
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-15 | 13F | Koesten, Hirschmann & Crabtree, INC. | 1 | 0 | ||||||
| 2025-08-13 | 13F | Renaissance Technologies Llc | 49.800 | 0,61 | 54 | -11,48 | ||||
| 2025-08-14 | 13F | Raymond James Financial Inc | 44 | 0 | ||||||
| 2025-08-14 | 13F | Susquehanna International Group, Llp | 27.606 | 49,98 | 30 | 30,43 | ||||
| 2025-07-24 | NP | FSMAX - Fidelity Extended Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value | 41.999 | 2,76 | 44 | -40,28 | ||||
| 2025-08-12 | 13F | Proequities, Inc. | Put | 0 | 0 | |||||
| 2025-08-14 | 13F | UBS Group AG | 22.592 | 89,59 | 25 | 71,43 | ||||
| 2025-09-04 | 13F/A | Advisor Group Holdings, Inc. | 305 | 2.950,00 | 0 | |||||
| 2025-08-12 | 13F | Proequities, Inc. | 0 | 0 | ||||||
| 2025-08-14 | 13F | Schonfeld Strategic Advisors LLC | 26.200 | 2,75 | 29 | -9,68 | ||||
| 2025-08-14 | 13F | Bank Of America Corp /de/ | 542 | 642,47 | 1 |
